YOLFTbeta
60

Sino-Argi Leading Biosciences

603970 · SHG · Basic Materials / Agricultural Inputs

9.87CNY-0.09 (-0.90%)

Price History

Full chart

Market Stats

Previous Close9.96
Open9.96
Day Range9.86 – 10.08
52-Week Range9.49 – 14.90
Volume1.42M
Market Cap3.18B
P/E (TTM)20.77
Forward P/E0.00
EPS0.57
Dividend Yield2.70%
Beta0.11
50-Day Avg10.84
200-Day Avg12.05

About

Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection products, application demonstrations, processing, and packaging. In addition, the company offers insecticides, fungicides, and herbicides products. The company was founded in 2009 and is headquartered in Beijing, China. Sino-Agri Leading Biosciences Co.,Ltd is a subsidiary of China National Agricultural Means of Production Group Corporation.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Baishu Huang
  • Employees736
  • HeadquartersGlobal Finance & News Center, Beijing, China, 100052, China
  • Websitehttps://www.sino-agri-sal.com

Leadership

  • Mr. Baishu HuangGM, Secretary & Director · b. 1979
  • Ms. Chanmi LeeAccounting Supervisor, Financial Director & Director · b. 1984
  • Mr. Kai KangDeputy GM, Operations Manager & Director · b. 1976
  • Mr. Mingguang LiExecutive VP & Director · b. 1972
  • Ms. Qing ChangDeputy GM, Deputy Secretary of the Party Branch & Director · b. 1979

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.14B2.49B2.88B3.23B3.40B3.50B3.73B4.34B6.64B8.82B11.70B10.46B10.60B11.24B
Growth (%)-+16.00%+15.56%+12.49%+5.08%+3.09%+6.60%+16.28%+52.93%+32.84%+32.61%-10.59%+1.30%+6.09%
Cost of Revenue1.93B2.20B2.52B2.84B3.00B3.09B3.33B3.90B6.13B8.29B10.97B9.76B9.88B10.50B
Gross Profit214.58M287.74M357.50M393.28M399.70M408.54M409.53M441.41M515.52M530.36M726.80M701.54M718.27M739.80M
Gross Margin10.00%11.56%12.43%12.16%11.76%11.66%10.97%10.16%7.76%6.01%6.21%6.71%6.78%6.58%
Operating Expense135.11M228.49M278.08M317.78M324.31M285.82M252.59M293.80M304.10M291.24M401.91M386.14M416.80M391.86M
Operating Income79.47M59.25M79.42M75.49M75.39M122.72M156.94M147.61M211.42M239.13M324.89M315.41M301.47M347.94M
Operating Margin3.71%2.38%2.76%2.33%2.22%3.50%4.20%3.40%3.18%2.71%2.78%3.02%2.85%3.10%
EBITDA81.16M118.45M167.18M191.43M200.77M180.13M194.51M216.79M262.23M289.91M365.13M341.62M345.14M283.14M
EBITDA Margin3.78%4.76%5.81%5.92%5.91%5.14%5.21%4.99%3.95%3.29%3.12%3.27%3.26%2.52%
Net Income55.46M68.72M80.72M88.27M81.72M90.33M115.46M118.88M132.44M170.31M210.32M224.84M203.38M172.53M
Net Income Margin2.59%2.76%2.81%2.73%2.40%2.58%3.09%2.74%1.99%1.93%1.80%2.15%1.92%1.53%
R&D1.37M1.74M2.32M1.18M1.07M3.74M12.38M30.81M34.04M37.53M45.79M65.36M66.74M66.41M
R&D as % of Total Revenue0.06%0.07%0.08%0.04%0.03%0.11%0.33%0.71%0.51%0.43%0.39%0.62%0.63%0.59%
Interest Expense017.23M42.17M59.93M65.15M29.82M16.54M47.84M48.56M39.52M43.87M15.63M32.96M22.97M
Interest Expense % of Total Revenue0.00%0.69%1.47%1.85%1.92%0.85%0.44%1.10%0.73%0.45%0.37%0.15%0.31%0.20%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.23B1.65B1.96B2.52B2.58B2.78B2.58B2.74B4.02B4.74B6.24B6.01B5.60B4.91B
Total Liabilities991.46M1.39B1.67B2.17B2.15B1.92B1.63B1.69B2.88B3.46B4.76B4.41B3.92B3.18B
Total Equity219.00M229.70M244.78M303.05M345.07M783.23M865.26M956.09M1.03B1.17B1.32B1.44B1.52B1.58B
Cash74.91M165.44M114.35M139.64M259.92M406.05M332.07M475.28M1.00B966.97M1.93B864.09M405.31M249.73M
Total Debt277.79M515.21M753.70M1.13B1.21B781.50M752.50M752.61M1.12B957.18M909.93M648.53M632.80M-
Net Debt202.89M349.77M639.35M988.86M950.14M375.45M420.43M277.33M120.00M-9.79M-1.02B-215.57M227.49M308.29M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow109.43M-79.66M40.41M-254.22M152.22M518.83M65.69M218.90M352.12M325.42M1.54B-919.85M307.40M-78.31M
Investing Cash Flow-1.04M-48.19M-124.08M7.41M-111.57M-222.03M22.30M-13.35M-287.45M78.02M-566.93M225.56M-199.52M-
Financing Cash Flow-102.46M202.79M36.85M235.51M20.75M-176.06M-92.42M-79.72M281.17M-313.20M-123.27M-328.26M-270.83M-
Capital Expenditure1.74M6.05M6.17M24.30M36.85M55.39M8.99M2.67M14.99M3.99M3.44M4.37M2.18M1.37M
Free Cash Flow107.70M-85.72M34.24M-278.52M115.37M463.44M56.70M216.23M337.13M321.43M1.53B-924.22M305.21M-79.68M
Dividends Paid55.70M70.92M108.82M83.80M105.87M95.20M71.52M40.04M48.00M57.60M67.20M123.44M145.02M143.11M
FCF to OCF98.41%107.60%84.73%109.56%75.79%89.32%86.32%98.78%95.74%98.77%99.78%100.47%99.29%101.75%
Dividend Paid to FCF51.71%-82.73%317.80%-30.09%91.76%20.54%126.13%18.52%14.24%17.92%4.39%-13.36%47.52%-179.61%

Earnings

Report DateApr 27, 2018Aug 29, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 26, 2020Oct 27, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate---------------------
EPS Actual0.120.300.040.090.100.220.040.080.110.330.080.090.180.290.090.120.170.350.110.150.20
Surprise---------------------
TimingPre-marketPre-market-------------------

Key Statistics & Ratios

Market Cap3.18B
Enterprise Value2.46B
Trailing P/E20.77
Forward P/E0.00
Price / Sales0.28
Price / Book1.86
EPS0.57
Book Value5.95
Revenue (TTM)11.32B
Gross Profit (TTM)694.07M
EBITDA269.69M
Profit Margin1.37%
Operating Margin2.75%
Return on Equity9.25%
Return on Assets2.47%
Shares Outstanding268.80M
Shares Float102.36M
Beta0.11
Dividend Yield2.70%
Dividend Rate0.32
Payout Ratio55.67%

Dividends

20231×
0.55Jun 13, 2023
20221×
0.25Jun 10, 2022
20211×
0.21Jun 28, 2021
20201×
0.18Jun 24, 2020
20191×
0.18Jun 18, 2019
20181×
0.15Jun 12, 2018

Stock Splits

  • Jun 13, 20237:5
  • Jun 18, 20196:5
  • Jun 12, 20186:5